Here is a video on Serum Imatinib (Gleevec) Levels Predict GIST Response. George D. Demetri, M.D., discusses how Gleevec levels  predict GIST response. Higher circulating levels of imatinib (Gleevec) correlated with better clinical responses in patients with gastrointestinal stromal tumors (GIST), but proper initial doses were unpredictable, a researcher reported here.

Learn about serum Imatinib (Gleevec) below: